{"slug":"confirmatory-trial-negative","tag":"confirmatory-trial-negative","variants":["confirmatory-trial-negative"],"description":"No description yet","count":1,"kinds":{"drug":1},"related":[],"records":[{"id":"enasidenib","kind":"drug","name":"Enasidenib","route":"/drugs/enasidenib/","status":"approved","tldr":"Enasidenib is the IDH2 counterpart of ivosidenib, approved in the US for relapsed disease but never approved in Europe after it failed to extend survival in a confirmatory trial."}]}